Promhex Plus Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 17-07-2024
- Paid Up Capital ₹ 0.18 M
as on 17-07-2024
- Company Age 7 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.04 Cr
as on 17-07-2024
- Revenue 23.81%
(FY 2023)
- Profit 2389.86%
(FY 2023)
- Ebitda 299.34%
(FY 2023)
- Net Worth 46.07%
(FY 2023)
- Total Assets -8.34%
(FY 2023)
About Promhex Plus Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.18 M.
The company currently has active open charges totaling ₹1.04 Cr.
Arati Kumari, Gunjan Sharma, Tariq Khan, and One other member serve as directors at the Company.
- CIN/LLPIN
U93000DL2017PTC323750
- Company No.
323750
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Sep 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Promhex Plus Healthcare?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arati Kumari  | Additional Director | 29-Sep-2021 | Current |
| Gunjan Sharma | Director | 15-Sep-2017 | Current |
| Tariq Khan | Director | 15-Sep-2017 | Current |
| Vikas Bhardwaj | Director | 02-Aug-2018 | Current |
Financial Performance and Corporate Structure Insights of Promhex Plus Healthcare.
Promhex Plus Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 23.81% increase. The company also saw a substantial improvement in profitability, with a 2389.86% increase in profit. The company's net worth Soared by an impressive increase of 46.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Promhex Plus Healthcare?
In 2023, Promhex Plus Healthcare had a promoter holding of 34.29% and a public holding of 65.71%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 30 Oct 2021 | ₹6.10 M | Open |
Hdfc Bank Limited Creation Date: 30 Oct 2021 | ₹4.30 M | Open |
How Many Employees Work at Promhex Plus Healthcare?
Promhex Plus Healthcare has a workforce of 10 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Promhex Plus Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Promhex Plus Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
